Three half-year reports, three kinds of profit quality

In brief

• Three fresh Hungarian corporate reports point to the same lesson: net profit alone does not explain how the underlying business performed.
• Tax moved the result at OPUS TIGÁZ, financing did so at Amixa, and dividend income did so at Prohuman, separating net profit from the operating path.
• Hungarian retail investors therefore need to read margins, cash flow, balance-sheet pressure and reporting scope alongside the bottom line.

Three half-year reports published on the Budapest Stock Exchange on 30 September offer an unusually comparable snapshot of how easily revenue, operating performance and profit attributable to shareholders can diverge. Regulated gas distributor OPUS TIGÁZ, food-trading group Amixa and staffing company Prohuman have different business models, yet give the same warning: eye-catching net-profit growth can be driven by tax or financial items while the core operation improves only slightly or weakens.

The stakes are direct for Hungarian investors because all three reports are domestic issuer disclosures, and in every case financing, costs incurred in forints and cash-generating ability shape room for manoeuvre in the next period. These numbers are not a buy or sell signal. They do, however, help separate operating earnings from one-off, tax-related or intra-group effects.

One revenue direction, three profit paths

The comparison uses current-period and comparative figures reported by the companies. OPUS TIGÁZ provides a standalone statement under Hungarian accounting rules for a regulated infrastructure company; Amixa provides a consolidated IFRS report for a trading group; Prohuman provides a separate IFRS report rather than a consolidated group view. Ranking the levels directly would therefore mislead, but comparing directions and margin changes remains informative.

| Company | Revenue, prior / current period | Operating profit, prior / current period | Net profit, prior / current period | |---|---:|---:|---:| | OPUS TIGÁZ | HUF m 27,630 / 29,315 | HUF m 6,294 / 6,337 | HUF m 3,414 / 4,407 | | Amixa | HUF m 7,775.459 / 8,334.498 | HUF m 333.783 / 441.122 | HUF m 127.703 / 32.761 | | Prohuman | HUF m 23,725.646 / 25,659.615 | HUF m 1,663.854 / 1,276.754 | HUF m 1,224.835 / 2,905.226 |

The calculated changes are as follows: OPUS TIGÁZ revenue +6.1%, operating profit +0.7%, net profit +29.1%; Amixa +7.2%, +32.2% and -74.3%; Prohuman +8.2%, -23.3% and +137.2%. Revenue growth is remarkably close across the three companies while net profit diverges. That is this analysis's main original finding: with similar top-line momentum, financing and tax structures created a larger difference than sales growth itself.

OPUS TIGÁZ's operating margin slipped from 22.8% to 21.6%, while its net margin rose from 12.4% to 15.0%. The explanation is not faster underlying operations: the tax obligation fell from HUF m 2,948 to 2,147, while profit before tax increased only from HUF m 6,362 to 6,553. Investment payments rose from HUF m 3,289 to 5,697. This can support long-term network development, but binds more cash in the short run.

At Amixa, the operating picture improved while net profit fell. Net financial expense increased from HUF m 113.655 to 371.054, and the fair-value change of cash-flow hedges reduced total comprehensive income. Management highlighted “stable operations” in the report. Operating improvement supports that statement, but the financing burden shows why stable operations are not the same as stable net profit.

At Prohuman, operating margin fell from 7.0% to 5.0%, while net margin rose from 5.2% to 11.3%. The reversal is mainly linked to HUF m 3,158.787 in dividend income. Operating cash flow meanwhile moved from positive HUF m 1,584.892 to HUF m -1,589.450. This does not make the profit worthless, but it gives it a different quality: financial income from the ownership structure is not the same as cash generated by serving customers.

What should a retail investor take away?

The first filter is reporting scope. Consolidated and separate accounts, and IFRS and Hungarian-accounting figures, should only be put side by side when the differences are made explicit. The second filter is the bridge from operating to net profit: interest, currency effects, dividends and tax need to be followed all the way through. The third is cash. Operating cash flow can worsen even when profit rises, while investment needs or short-term financing may increase.

In the next reports, investors should watch whether OPUS TIGÁZ preserves its operating cash surplus alongside higher investment. At Amixa, financial expense, the hedge position and equity will be decisive. At Prohuman, the question is whether core operating margin and cash flow recover once the large dividend income no longer distorts the comparison to the same extent.

Another lesson from the comparison is that profit quality cannot be compressed into one universal measure. Regulated assets, working-capital needs and intra-group financing shape cash differently. Investors can therefore keep a company-specific checklist covering operating margin, the bridge to profit before tax, operating cash flow, net debt, investment and management's source-backed outlook. That produces a more disciplined reading than the headline profit and avoids a rushed conclusion.

The forint can affect the three models differently. Import and financing exposure is more direct at Amixa, largely passes through costs and clients at Prohuman, and can reach OPUS TIGÁZ through investment procurement and regulatory settlement. The reports do not provide a full breakdown for every currency exposure, so we do not state a numerical exchange-rate sensitivity.

Methodology. We calculated growth as the change between the current and comparative period divided by the comparative base, and margins as profit divided by revenue. Sources are the OPUS TIGÁZ report, the Amixa report and the Prohuman report. Related coverage: OPUS TIGÁZ, Amixa, Prohuman.